Rebecca B. Riggins, Ph.D.
Affiliations: | 2003 | University of Virginia, Charlottesville, VA |
Area:
Microbiology Biology, Cell Biology, Molecular Biology, OncologyGoogle:
"Rebecca Riggins"Parents
Sign in to add mentor| Amy H. Bouton | grad student | 2003 | UVA | |
| (*Cas and AND-34 promote ac -Src activation, cell migration, and antiestrogen resistance.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bahnassy S, Stires H, Jin L, et al. (2023) Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer. Endocrinology. 164 |
| Olukoya AO, Stires H, Bahnassy S, et al. (2023) Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer. Journal of the Endocrine Society. 7: bvad117 |
| Riggins RB, Ranjit S. (2023) Targeting the NAD+ Salvage Pathway: Synergistic Therapeutic Strategy for ER+ Metastatic Breast Cancer. Endocrinology |
| Bahnassy S, Stires H, Jin L, et al. (2023) Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer. Biorxiv : the Preprint Server For Biology |
| Gaymon DO, Barndt R, Stires H, et al. (2023) ROS is a master regulator of in vitro matriptase activation. Plos One. 18: e0267492 |
| Williams MM, Spoelstra NS, Arnesen S, et al. (2020) Steroid hormone receptor and infiltrating immune cell status reveals therapeutic vulnerabilities of ESR1 mutant breast cancer. Cancer Research |
| Zhang YW, Nasto RE, Jablonski SA, et al. (2020) RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attack. Methods in Enzymology. 636: 299-322 |
| Olukoya AO, Stires H, Guerra Y, et al. (2020) SAT-119 Targeting Glutamate Metabolism and Signaling in ER+, Endocrine Therapy-Resistant Breast Cancer Journal of the Endocrine Society. 4 |
| Boca S, Bhuvaneshwar K, Fernandez-Vega V, et al. (2020) Prioritizing targeted therapies in an evidence-based manner, integrating biological context and functional precision medicine. Journal of Clinical Oncology. 38: e14065-e14065 |
| Fernandez AI, Geng X, Chaldekas K, et al. (2019) The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancer. Breast Cancer Research and Treatment |